About Cartilago
Cartilago is a Healthcare company based in Maglie (Italy) founded in 2018. It operates as a molecular technology for regenerative medicine is developed by Cartilago. Cartilago offers products and services including Peptidyl Derivatives. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its competitors include SpringWorks Therapeutics, Humacyte, Avita Medical, MiMedx Group and Ossio and 5 more; 8 of its 10 listed competitors have raised funding.
Company details
Cartilago was founded in 2018 in Maglie, Italy, within the regenerative medicine sector. Molecular technologies are developed to repair and regenerate extracellular matrix and tissues. Products include Regen NAPA for osteoarthritis treatment, Regen Longevity for anti-aging applications, NCPA for bone tumors, and LT Coating for orthopedic implants. Operations focus on disease-modifying chondroprotective solutions for musculoskeletal conditions.
- Headquarters Maglie, Italy
- SectorsHealthcare
- Email••••••••
- Website cartilago.it
Products & Services of Cartilago
Cartilago offers a comprehensive portfolio of products and services, including Peptidyl Derivatives.
Stimulates cartilage and tissue regeneration for osteoarthritis treatment.
Competitors of Cartilago
Cartilago has 10 listed competitors in our database, 8 of them funded. They include SpringWorks Therapeutics, Humacyte, Avita Medical, MiMedx Group and Ossio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| springworkstx.com | 2017 | New York, United States | $229.6M | 305 | Small molecule therapeutics are developed for cancer and rare diseases. | |
| humacyte.com | 2004 | Morrisville, United States | $424.76M | 70 | Human tissue-based products are developed for vascular disease applications. | |
| avitamedical.com | 1992 | Cambridge, United Kingdom | – | 108 | Products for regenerative and respiratory medicine are developed and distributed. | |
| mimedx.com | 1985 | Marietta, United States | – | 735 | Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | |
| ossio.io | 2014 | Caesarea, Israel | $89.01M | – | Orthopedic fixation is enabled by bone regeneration biocomposite technology. | |
| theradaptive.com | 2004 | Boston, United States | $32.2M | 21 | Therapeutic delivery platform is developed for orthopedic clinical indications. | |
| epibone.com | 2013 | Brooklyn, United States | $48.63M | – | Developer of stem cells to regrow damaged bones | |
| biocomposites.com | 1999 | Keele, United Kingdom | $1.8M | – | Synthetic calcium composites are developed for bone repair and regeneration. | |
| cartiheal.com | 2009 | Kfar Saba, Israel | $65.8M | – | Implants for bone and cartilage regeneration are developed and provided. | |
| revbio.com | 2014 | Lowell, United States | $24.42M | – | Synthetic adhesives for bone and dental repair are developed. |
Detailed competitors of Cartilago
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cartilago
The website of Cartilago (cartilago.it) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 121.3% vs previous month
Top companies in Orthopedics
10 companies that operate in the same segment as Cartilago (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | – | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cartilago
Cartilago was founded in 2018.
Cartilago is headquartered in Maglie, Italy. It is registered at Maglie, Apulia, Italy.
Cartilago was founded in 2018 in Maglie, Italy, within the regenerative medicine sector. Molecular technologies are developed to repair and regenerate extracellular matrix and tissues. Products include Regen NAPA for osteoarthritis treatment, Regen Longevity for anti-aging applications, NCPA for bone tumors, and LT Coating for orthopedic implants. Operations focus on disease-modifying chondroprotective solutions for musculoskeletal conditions.
Cartilago's top competitors include SpringWorks Therapeutics, Humacyte and EpiBone.
Cartilago offers Peptidyl Derivatives.